van Baal, PHMWong, ASlobbe, LCJPolder, JJBrouwer, WBFde Wit, GA2025-03-202025-03-2020112118461810.2165/11586130-000000000-00000https://rivm.openrepository.com/handle/10029/645689Standardizing the inclusion of indirect medical costs in economic evaluationsArticlePharmacoeconomics 2011; 29(3):175-872025-03-20